Federal Circuit agrees with PTAB in optical patent appeal
21-01-2021
Allergan and tribe to appeal PTAB’s immunity decision
02-03-2018
Native American tribe not entitled to sovereign immunity: PTAB
26-02-2018
bee32 / iStockphoto.com
Allergan and the Saint Regis Mohawk Tribe have argued that the Patent Trial and Appeal Board (PTAB) doesn’t have the jurisdiction to decide on the validity of patents concerning a dry-eye treatment while its recent decision is being appealed.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
generics, Restasis, patent invalidation, Allergan, Saint Regis Mohawk Tribe, PTAB, IPR, sovereign immunity, US Court of Appeals for the Federal Circuit
